These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9501807)

  • 1. Colorectal cancer vaccines.
    Maxwell-Armstrong CA; Durrant LG; Scholefield JH
    Br J Surg; 1998 Feb; 85(2):149-54. PubMed ID: 9501807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in heat shock protein-based cancer vaccines.
    Wang HH; Mao CY; Teng LS; Cao J
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):22-7. PubMed ID: 16481277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer vaccination.
    Del Vecchio M; Parmiani G
    Forum (Genova); 1999; 9(3):239-56. PubMed ID: 10504171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial.
    Harrop R; Connolly N; Redchenko I; Valle J; Saunders M; Ryan MG; Myers KA; Drury N; Kingsman SM; Hawkins RE; Carroll MW
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3416-24. PubMed ID: 16740766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor vaccination: where we stand.
    Bocchia M; Bronte V; Colombo MP; De Vincentiis A; Di Nicola M; Forni G; Lanata L; Lemoli RM; Massaia M; Rondelli D; Zanon P; Tura S
    Haematologica; 2000 Nov; 85(11):1172-206. PubMed ID: 11074658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically modified tumour vaccines--where we are today.
    Nawrocki S; Mackiewicz A
    Cancer Treat Rev; 1999 Feb; 25(1):29-46. PubMed ID: 10212588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer vaccines: what we know and what we don't yet know.
    von Mehren M
    Semin Oncol; 2005 Feb; 32(1):76-84. PubMed ID: 15726509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials.
    Mosolits S; Nilsson B; Mellstedt H
    Expert Rev Vaccines; 2005 Jun; 4(3):329-50. PubMed ID: 16026248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New strategies to improve the efficacy of colorectal cancer vaccines: from bench to bedside.
    Mocellin S
    Curr Opin Investig Drugs; 2006 Dec; 7(12):1052-61. PubMed ID: 17209522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts in immunotherapy for the treatment of colorectal cancer.
    Indar A; Maxwell-Armstrong CA; Durrant LG; Carmichael J; Scholefield JH
    J R Coll Surg Edinb; 2002 Apr; 47(2):458-74. PubMed ID: 12018689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer vaccines, a critical review--Part II.
    Mitchell MS
    Curr Opin Investig Drugs; 2002 Jan; 3(1):150-8. PubMed ID: 12054066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active specific immunotherapy for colorectal cancer.
    Indar AA; Maxwell-Armstrong CA
    Expert Rev Anticancer Ther; 2003 Oct; 3(5):685-94. PubMed ID: 14599091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccination against tumors.
    Prud'homme GJ
    J Gene Med; 2005 Jan; 7(1):3-17. PubMed ID: 15538731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock proteins gp96 as immunogens in cancer patients.
    Parmiani G; De Filippo A; Pilla L; Castelli C; Rivoltini L
    Int J Hyperthermia; 2006 May; 22(3):223-7. PubMed ID: 16754342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-shock protein-based anticancer immunotherapy: an idea whose time has come.
    Ménoret A; Chandawarkar R
    Semin Oncol; 1998 Dec; 25(6):654-60. PubMed ID: 9865680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients.
    Conry RM; Curiel DT; Strong TV; Moore SE; Allen KO; Barlow DL; Shaw DR; LoBuglio AF
    Clin Cancer Res; 2002 Sep; 8(9):2782-7. PubMed ID: 12231517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines for colorectal cancer and renal cell carcinoma.
    Kabaker K; Shell K; Kaufman HL
    Cancer J; 2011; 17(5):283-93. PubMed ID: 21952277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor antigens as surrogate markers and targets for therapy and vaccines.
    Dalgleish A; Pandha H
    Adv Cancer Res; 2007; 96():175-90. PubMed ID: 17161680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.